Trial Data on Kite’s Lead Candidate for B-Cell Lymphomas to Be Presented at Meeting
News
Kite Pharma will present data from multiple clinical trials of KTE-C19, the company’s lead candidate CAR-T cell therapy for B-cell lymphomas and leukemias at the American Society of Hematology (ASH) ... Read more